中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 4
Apr.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(4): 805-809

Value of red blood cell distribution width-to-platelet ratio in evaluating metabolic-associated fatty liver disease and liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2022.04.013
  • a.

    Department of General Medicine, Shengjing Hospital, China Medical University, Shenyang 110004, China

  • b.

    Department of Gastroenterology, Shengjing Hospital, China Medical University, Shenyang 110004, China

Research funding:

Shenyang Science and Technology Plan Project (F14-158-9-49)

More Information
  • Corresponding author: PEI Dongmei, peidm@sj-hospital.org(ORCID: 0000-0002-1947-4447)
  • Received Date: 2021-08-30
  • Accepted Date: 2021-10-11
  • Published Date: 2022-04-20
    Abstract
  •   Objective  To investigate the clinical significance of red blood cell distribution width-to-platelet ratio (RPR index) in evaluating the severity of metabolic-associated fatty liver disease and predicting fatty liver-associated cirrhosis.  Methods  A total of 192 patients with metabolic-associated fatty liver disease and 210 patients with fatty liver-associated cirrhosis who were admitted to Shengjing Hospital of China Medical University from January 2019 to June 2020 were enrolled as group A and group B, respectively, and 206 individuals who underwent physical examination in our hospital during the same period of time were enrolled as control group (group C). All subjects underwent general measurement, blood cell analysis, blood biochemical test, and abdominal CT examination, and related formulas were used to calculate RPR, aspartate aminotransferase-to-platelet ratio index (APRI), and fibrosis-4 (FIB-4) index. A one-way analysis of variance was used for comparison of continuous data with homogeneity of variance between groups, and the SNK method was used for comparison between two groups; the Kruskal-Wallis H test was used for comparison of continuous data with heterogeneity of variance between groups, and the Mann-Whitney U test was used for comparison between two groups; the chi-square test was used for comparison of categorical data between groups; the receiver operating characteristic (ROC) curve was used to analyze the accuracy of the prediction of liver cirrhosis.  Results  There were significant differences in red blood cell distribution width-standard deviation, albumin, creatinine, body mass index, RPR, and APRI between any two groups (all P < 0.001), and there were significant differences in white blood cell count, platelet count, alanine aminotransferase, aspartate aminotransferase, direct bilirubin, blood urea nitrogen, and FIB-4 between group A and group B (all P < 0.05). There were significant differences in waist circumference and fasting blood glucose between groups A and B and between groups A and C (all P < 0.001). There was a significant difference in RPR between any two groups of the mild, moderate, and severe metabolic-associated fatty liver disease groups (all P < 0.05). In terms of diagnostic efficiency, the three noninvasive models RPR, APRI, and FIB-4 had an area under the ROC curve of 0.932, 0.815, and 0.877, respectively, in predicting fatty liver-associated cirrhosis.  Conclusion  There is a difference in RPR index between different stages of liver disease, and RPR index gradually increases with the aggravation of metabolic-associated fatty liver disease. RPR index has a higher value than APRI and FIB-4 in the warning of fatty liver-associated cirrhosis.

     

    • FullText(HTML)
  • loading
    • References(20)
  • [1]
    YOUNOSSI ZM, KOENIG AB, ABDELATIF D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1): 73-84. DOI: 10.1002/hep.28431.
    [2]
    XUE R, FAN JG. Brief introduction of an international expert consensus statement: A new definition of metabolic associated fatty liver disease[J]. J Clin Hepatol, 2020, 36(6): 1224-1227. DOI: 10.3969/j.issn.1001-5256.2020.06.007.

    薛芮, 范建高. 代谢相关脂肪性肝病新定义的国际专家共识简介[J]. 临床肝胆病杂志, 2020, 36(6): 1224-1227. DOI: 10.3969/j.issn.1001-5256.2020.06.007.
    [3]
    LEONI S, TOVOLI F, NAPOLI, et al. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis[J]. World J Gastroenterol, 2018, 24(30): 3361-3373. DOI: 10.3748/wjg.v24.i30.3361.
    [4]
    SHIHA G, ALSWAT K, AL KHATRY M, et al. Nomenclature and definition of metabolic-associated fatty liver disease: A consensus from the Middle East and north Africa[J]. Lancet Gastroenterol Hepatol, 2021, 6(1): 57-64. DOI: 10.1016/S2468-1253(20)30213-2.
    [5]
    SHIHA G, IBRAHIM A, HELMY A, et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: A 2016 update[J]. Hepatol Int, 2017, 11(1): 1-30. DOI: 10.1007/s12072-016-9760-3.
    [6]
    WAI CT, GREENSON JK, FONTANA RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J]. Hepatology, 2003, 38(2): 518-526. DOI: 10.1053/jhep.2003.50346.
    [7]
    WANG H, WANG J, XIA J, et al. Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis[J]. Medicine (Baltimore), 2020, 99(34): e21408. DOI: 10.1097/MD.0000000000021408.
    [8]
    ZHU LY, LI YC, DENG LH, et al. Research advances in extrahepatic diseases associated with nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2021, 37(9): 2215-2219. DOI: 10.3969/j.issn.1001-5256.2021.09.043.

    朱蕗颖, 李雨晨, 邓利华, 等. 非酒精性脂肪性肝病相关肝外疾病的研究进展[J]. 临床肝胆病杂志, 2021, 37(9): 2215-2219. DOI: 10.3969/j.issn.1001-5256.2021.09.043.
    [9]
    MOTAMED N, RABIEE B, HEMASI GR, et al. Body roundness index and waist-to-height ratio are strongly associated with non-alcoholic fatty liver disease: A population-based study[J]. Hepat Mon, 2016, 16(9): e39575. DOI: 10.5812/hepatmon.39575.
    [10]
    CUI HZ, MA XM, LIU Q, et al. Influence of the interaction between abdominal obesity and hypertriglyceridemia on the development of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2020, 36(6): 1314-1319. DOI: 10.3969/j.issn.1001-5256.2020.06.025.

    崔皓哲, 马向明, 刘倩, 等. 腹型肥胖与甘油三酯的交互作用对非酒精性脂肪性肝病发病的影响[J]. 临床肝胆病杂志, 2020, 36(6): 1314-1319. DOI: 10.3969/j.issn.1001-5256.2020.06.025.
    [11]
    CETINKAYA E, SENOL K, SAYLAM B, et al. Red cell distribution width to platelet ratio: New and promising prognostic marker in acute pancreatitis[J]. World J Gastroenterol, 2014, 20(39): 14450-14454. DOI: 10.3748/wjg.v20.i39.14450.
    [12]
    PUSUROGLU H, CAKMAK HA, AKGUL O, et al. The prognostic value of admission red cell distribution width-to-platelet ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Rev Port Cardiol, 2015, 34(10): 597-606. DOI: 10.1016/j.repc.2015.03.014.
    [13]
    JIANG X, WANG Y, SU Z, et al. Red blood cell distribution width to platelet ratio levels in assessment of histologic severity in patients with primary biliary cholangitis[J]. Scand J Clin Lab Invest, 2018, 78(4): 258-263. DOI: 10.1080/00365513.2018.1449011.
    [14]
    XIE S, CHEN X. Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus[J]. Medicine (Baltimore), 2018, 97(39): e12342. DOI: 10.1097/MD.0000000000012342.
    [15]
    CAI Y, LIU D, CUI J, et al. Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting staging liver fibrosis in chronic liver disease patients: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2019, 98(14): e15096. DOI: 10.1097/MD.0000000000015096.
    [16]
    SALVAGNO GL, SANCHIS-GOMAR F, PICANZA A, et al. Red blood cell distribution width: A simple parameter with multiple clinical applications[J]. Crit Rev Clin Lab Sci, 2015, 52(2): 86-105. DOI: 10.3109/10408363.2014.992064.
    [17]
    LI N, ZHOU H, TANG Q. Red blood cell distribution width: A novel predictive indicator for cardiovascular and cerebrovascular diseases[J]. Dis Markers, 2017, 2017: 7089493. DOI: 10.1155/2017/7089493.
    [18]
    LYU H, ZHU CL, HAO SY. Change and significance of red cell distribution width in patients with non-alcoholic steatohepatitis[J]. J Chin Pract Diagn Ther, 2016, 30(8): 765-766. DOI: 10.13507/j.issn.1674-3474.2016.08.013.

    吕辉, 祝成亮, 郝世勇. 非酒精性脂肪性肝炎患者红细胞分布宽度变化及意义[J]. 中华实用诊断与治疗杂志, 2016, 30(8): 765-766. DOI: 10.13507/j.issn.1674-3474.2016.08.013.
    [19]
    LI Y, DAI ZY, HUANG JJ, et al. Differences of erythrocyte distribution width and prothrombin time in patients with different degrees of liver injury[J]. Chongqing Med, 2017, 46(36): 5074-5075. DOI: 10.3969/j.issn.1671-8348.2017.36.012.

    李月, 代震宇, 黄佳佳, 等. 不同程度肝损伤患者红细胞分布宽度与凝血酶原时间的差异[J]. 重庆医学, 2017, 46(36): 5074-5075. DOI: 10.3969/j.issn.1671-8348.2017.36.012.
    [20]
    MALEHMIR M, PFISTER D, GALLAGE S, et al. Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer[J]. Nat Med, 2019, 25(4): 641-655. DOI: 10.1038/s41591-019-0379-5.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (771) PDF downloads(89) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return